Simon Schwartz Navarro Senior scientist and advisor with specific interest in Nanomedicine and Advanced Therapies applied to unmet clinical needs. I am also acting as strategy coordinator to facilitate programs and initiatives that foster innovation in new treatments and diagnostic tools. Institutions of which they are part Main researcher Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Cap de Secció Bioquímica Cross-departmental services LinkedIn Twitter Orcid Simon Schwartz Navarro LinkedIn Twitter Orcid Institutions of which they are part Main researcher Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Cap de Secció Bioquímica Cross-departmental services Senior scientist and advisor with specific interest in Nanomedicine and Advanced Therapies applied to unmet clinical needs. I am also acting as strategy coordinator to facilitate programs and initiatives that foster innovation in new treatments and diagnostic tools.
Senior research of the clinical biochemistry - drug delivery and therapy group at VHIR and Strategy director of biobanking and biomodels at Vall d'hebron Campus. President of the European Society of Nanomedicine and Executive Board member of the International Society of Nanomedicine. Former director general of the Blood and Tissue Banc of Catalonia. Former director of CIBBIM-Nanomedicine. Former scientific associate director of CIBER-BBN and coordinator of technology transfer. Former director assistance of translational research at VHIR. H-index of 48, with more that 120 high impact publications, 19 transferred patents and several EU granted projects. Co-founder of 3 biotech companies (i.e, Bsure Medical ltd). Science Advisor of the European Nanomedicine Characterization Laboratory (EU-NCL). Member of the editorial Board of Precision Nanomedicine, J. Nanotechnology and of J. of Nanotheranostics. Former editorial Board member of Eur. J. Nanomedicine and Nanomedicine-NBM. Exper member of the nanomedicine group at EMA.
Projects Validación Funcional de dianas terapéuticas y nuevas nanomedicinas en modelos in vitro e in vivo de cáncer colorectal IP: Simon Schwartz Navarro Collaborators: - Funding agency: Fundació Institut de Recerca HUVH Funding: 13000 Reference: PRED/IR-HUVH/13/2007 Duration: 01/01/2008 - 31/12/2011 Investigación y desarrollo de productos y tecnologías de diagnóstico-pronóstico y aplicaciones terapéuticas en la enfermedad neoplásica. IP: Simon Schwartz Navarro Collaborators: Manuel Armengol Carrasco, Eloy Espín Basany Funding agency: Oncnosis Pharma, AIE Funding: 249000 Reference: CENIT/02/2006 Duration: 01/04/2006 - 31/12/2009 Nuevos transductores para Kras y BRAF en cáncer colorectal con inestabilidad de microsálites esporádico y hereditario: diferencias de activación según el entorno molecular tumoral. IP: Simon Schwartz Navarro Collaborators: Eloy Espín Basany Funding agency: Instituto de Salud Carlos III Funding: 97580 Reference: PI050304 Duration: 01/01/2006 - 31/12/2008 Oncologia Molecular i Envelliment IP: Simon Schwartz Navarro Collaborators: Alberto Plaja Rustein, Teresa Vendrell Bayona, Manuel Armengol Carrasco, Eloy Espín Basany Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 36600 Reference: 2005SGR 00076 Duration: 01/01/2006 - 31/12/2008 Pagination First page « Previous page ‹ … Page 8 Page 9 Current page 10 Page 11 Page 12 Next page › Last page »
